EXHIBIT 21.1
SUBSIDIARIES OF FORTRESS BIOTECH, INC.
Subsidiaries of Fortress Biotech, Inc. at December 31, 2018, with jurisdiction of incorporation or formation:
| · | Aevitas Therapeutics, Inc. (Delaware) | |
| · | Avenue Therapeutics, Inc. (Delaware)’ | |
| · | Caelum Biosciences, Inc. (Delaware), formerly FBIO Acquisition Corp. II | |
| · | CB Securities Corporation (Massachusetts) | |
| · | Cellvation Inc. (Delaware), formerly FBIO Acquisition Corp. I | |
| · | Checkpoint Therapeutics, Inc. (Delaware) | |
| · | Cyprium Therapeutics, Inc. (Delaware) | |
| · | Coronado SO Co. (Delaware) | |
| · | Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc. (Delaware) | |
| · | FBIO Acquisition Corp. IV, VI – XIV (Delaware) | |
| · | GeneXion Oncology, Inc. (Delaware), formerly FBIO Acquisition Corp. III | |
| · | Helocyte, Inc., formerly DiaVax Biosciences, Inc. (Delaware) | |
| · | Innmune Limited (United Kingdom) | |
| · | Journey Medical Corporation (Delaware) | |
| · | Mustang Bio, Inc. (Delaware) | |
| · | Tamid Bio, Inc. (Delaware), formerly FBIO Acquisition Corp. V | |
| · | Fortress Biotech, China, Inc. |